What is Igor Beuker's peptide forecast for 2030?

Peptide drugs, Ozempic and Wegovy included, pass $150 billion a year by 2030, from about $100 billion in 2026, against the analysts' consensus of $84 billion. Healing peptides go legal by phone across the US after the FDA panel of July 2026, Europe and the UK still ban them, BPC-157 gets its first 1,000-person trial, and the first peptide death lawsuit reaches a US court.